About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

ROHTO PHARMACEUTICAL CO.,LTD.(4527) Summary

4527
TSE Prime
ROHTO PHARMACEUTICAL CO.,LTD.
2,157.5
JPY
-45.0
(-2.04%)
Apr 4, 1:54 pm JST
14.84
USD
Apr 4, 12:55 am EDT
Result
PTS
outside of trading hours
2,157.2
Apr 4, 1:55 pm JST
Summary Chart Historical News Financial Result
PER
15.1
PBR
1.91
Yield
1.67%
Margin Trading Ratio
6.61
Stock Price
Apr 4, 2025
Opening Apr 4, 9:00 am
2,182.5 JPY 14.92 USD
Previous Close Apr 3
2,202.5 JPY 14.95 USD
High Apr 4, 9:34 am
2,215.0 JPY 15.16 USD
Low Apr 4, 1:53 pm
2,156.0 JPY 14.81 USD
Volume
830,900
Trading Value
1.82B JPY 0.01B USD
VWAP
2185.59 JPY 15.03 USD
Minimum Trading Value
215,750 JPY 1,484 USD
Market Cap
0.51T JPY 3.52B USD
Number of Trades
3,327
Liquidity & Number of Trades
As of Apr 4, 2025
Liquidity
High
1-Year Average
2,728
1-Year High Nov 14, 2024
12,968
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 28, 2025 115,400 1,116,100 9.67
Mar 21, 2025 128,300 985,200 7.68
Mar 14, 2025 127,900 963,500 7.53
Mar 7, 2025 130,800 988,600 7.56
Feb 28, 2025 124,700 935,400 7.50
Company Profile
ROHTO PHARMACEUTICAL CO.,LTD. is the leading manufacturer of over-the-counter eye drops. The company's skincare cosmetics have shown rapid growth. It also develops functional foods and regenerative medicine products.
Sector
Pharmaceuticals
ROHTO PHARMACEUTICAL CO.,LTD. specializes in manufacturing and selling products primarily in eye care and skincare categories, as well as internal medicines. The company operates globally, with a focus on Japan and expanding into America, Europe, and Asia. In Japan, its main business is the production and sale of eye drops and skincare products, while in Western markets, it primarily offers skincare-related products. In Asian regions, the company provides a wide range of products including eye care items. ROHTO has numerous consolidated subsidiaries: 14 in Japan, 9 in America, 8 in Europe, and 14 in Asia, along with many affiliated companies. This extensive network allows the company to develop products and implement sales strategies tailored to each region's characteristics. Focusing on the health and beauty care sector, ROHTO meets diverse consumer needs through its global business operations, offering a wide array of products.